Tesla Sues EV-Battery-Supplier Matthews Over Alleged Disclosure of Trade Secrets
By Sabela Ojea
Tesla has sued electric-vehicle-battery-supplier Matthews International for allegedly disclosing its confidential trade secrets to other companies, including competitors.
According to the lawsuit, filed on Friday in the Northern District of California, Matthews breached its contract and allegedly improperly filed patent applications incorporating Tesla's trade secrets without the electric-vehicle maker's consent.
The Texas-based company said that, unless Matthews is enjoined from continuing its allegedly unlawful actions, Tesla would suffer immediate and irreparable harm after suffering monetary damages of over $75,000 that would likely exceed $1 billion.
Tesla requests an order requiring Matthews to pay Tesla its damages, costs, expenses, and pre-judgment and post-judgment interest for Matthews's improper acts.
"Since discovering Matthews' improper conduct, Tesla has been working to block and/or delay publication of affected applications, and only a subset of Tesla's confidential information regarding dry-electrode manufacturing has published thus far," the lawsuit said.
In 2019, Tesla selected Matthews to be one of its suppliers for equipment that it used to refine its dry-electrode-battery manufacturing and to put it into mass production.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
June 17, 2024 14:02 ET (18:02 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks